SCHEMBL29626602

SCHEMBL29626602

CC(O)c1cccc(-c2cc(-c3ccccc3)no2)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 7/20 0.60
▸ RAB9A P51151 7/20 0.60
▸ CASP3 P42574 1/20 0.55
▸ SENP8 Q96LD8 1/20 0.55
▸ SENP7 Q9BQF6 1/20 0.55
▸ SENP6 Q9GZR1 1/20 0.55
▸ HSD17B1 P14061 1/20 0.52
▸ HSD17B2 P37059 1/20 0.52
▸ BRD4 O60885 1/20 0.52
▸ BRD2 P25440 1/20 0.52
▸ CREBBP Q92793 1/20 0.52
▸ MEN1 O00255 4/20 0.50
▸ KMT2A Q03164 4/20 0.50
▸ CYP2C9 P11712 2/20 0.50
▸ CYP2C19 P33261 2/20 0.50
▸ CYP1A2 P05177 1/20 0.50
▸ HPGD P15428 1/20 0.50
▸ NFKB1 P19838 1/20 0.50
▸ NFKB2 Q00653 1/20 0.50
▸ RELA Q04206 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28741820 1.00 NPC1 (0.60) NPC1RAB9ACASP3SENP8SENP7
SCHEMBL21466382 0.82 RAB9A (0.64) NPC1RAB9ACASP3SENP8SENP7
SCHEMBL28680088 0.77 NPC1 (0.71) NPC1RAB9ACASP3SENP8SENP7
SCHEMBL17019497 0.77 NPC1 (0.71) NPC1RAB9ACASP3SENP8SENP7
3,5-Diphenylisoxazole SCHEMBL1421260 0.77 NPC1 (1.00) NPC1RAB9ACASP3SENP8SENP7
SCHEMBL13921154 0.76 NPC1 (0.73) NPC1RAB9ACASP3SENP8SENP7
SCHEMBL7670373 0.75 PTPN5 (0.59) BRD4BRD2CREBBPMEN1KMT2A
SCHEMBL8258186 0.75 NPC1 (0.96) NPC1RAB9ACASP3SENP8SENP7
SCHEMBL18974099 0.74 CHRM2 (0.54) NPC1RAB9ACASP3SENP8SENP7
SCHEMBL30422500 0.74 NPC1 (0.72) NPC1RAB9ACASP3SENP8SENP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114450271-B Ureas, amino and substituted heteroaryl compounds for Cbl-b inhibition 纽力克斯治疗公司 2024-09-20 — — CN disclosed
EP-4003965-A1 UREA, AMIDE, AND SUBSTITUTED HETEROARYL COMPOUNDS FOR CBL-B INHIBITION Nurix Therapeutics, Inc. (US) 2022-06-01 — — EP disclosed
CN-114450271-A Ureas, amino and substituted heteroaryl compounds for Cbl-b inhibition 纽力克斯治疗公司 2022-05-06 — — CN disclosed
Send feedback